Cargando…

Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tiss...

Descripción completa

Detalles Bibliográficos
Autores principales: Sequeira, Vasco, Wang, Lili, Wijnker, Paul J.M., Kim, Kyungsoo, Pinto, Jose R., dos Remedios, Cris, Redwood, Charles, Knollmann, Bjorn C., van der Velden, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160007/
https://www.ncbi.nlm.nih.gov/pubmed/37159677
http://dx.doi.org/10.1016/j.jmccpl.2022.100007
_version_ 1785037194038083584
author Sequeira, Vasco
Wang, Lili
Wijnker, Paul J.M.
Kim, Kyungsoo
Pinto, Jose R.
dos Remedios, Cris
Redwood, Charles
Knollmann, Bjorn C.
van der Velden, Jolanda
author_facet Sequeira, Vasco
Wang, Lili
Wijnker, Paul J.M.
Kim, Kyungsoo
Pinto, Jose R.
dos Remedios, Cris
Redwood, Charles
Knollmann, Bjorn C.
van der Velden, Jolanda
author_sort Sequeira, Vasco
collection PubMed
description BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tissue and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to gain insight into how the balance between mutant and WT protein expression affects cardiomyocyte function. METHODS: Force measurements were performed in cardiomyocytes isolated from a HCM patient carrying a homozygous troponin T mutation (cTnT-K280N) and healthy donors. To discriminate between mutation-mediated and phosphorylation-related effects on Ca(2+)-sensitivity, cardiomyocytes were treated with alkaline phosphatase (AP) or protein kinase A (PKA). Troponin exchange experiments characterized the relation between mutant levels and myofilament function. To define mutation-mediated effects on Ca(2+)-dynamics we used CRISPR/Cas9 to generate hiPSC-CMs harbouring heterozygous and homozygous TnT-K280N mutations. Ca(2+)-transient and cell shortening experiments compared these lines against isogenic controls. RESULTS: Myofilament Ca(2+)-sensitivity was higher in homozygous cTnT-K280N cardiomyocytes and was not corrected by AP- and PKA-treatment. In cTnT-K280N cells exchanged with cTnT-WT, a low level (14%) of cTnT-K280N mutation elevated Ca(2+)-sensitivity. Similarly, exchange of donor cells with 45 ± 2% cTnT-K280N increased Ca(2+)-sensitivity and was not corrected by PKA. cTnT-K280N hiPSC-CMs show elevated diastolic Ca(2+) and increases in cell shortening. Impaired cardiomyocyte relaxation was only evident in homozygous cTnT-K280N hiPSC-CMs. CONCLUSIONS: The cTnT-K280N mutation increases myofilament Ca(2+)-sensitivity, elevates diastolic Ca(2+), enhances contractility and impairs cellular relaxation. A low level (14%) of the cTnT-K280N sensitizes myofilaments to Ca(2+), a universal finding of human HCM.
format Online
Article
Text
id pubmed-10160007
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier, Inc
record_format MEDLINE/PubMed
spelling pubmed-101600072023-05-06 Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy Sequeira, Vasco Wang, Lili Wijnker, Paul J.M. Kim, Kyungsoo Pinto, Jose R. dos Remedios, Cris Redwood, Charles Knollmann, Bjorn C. van der Velden, Jolanda J Mol Cell Cardiol Plus Article BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant genetic disorder with patients typically showing heterozygous inheritance of a pathogenic variant in a gene encoding a contractile protein. Here, we study the contractile effects of a rare homozygous mutation using explanted tissue and human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to gain insight into how the balance between mutant and WT protein expression affects cardiomyocyte function. METHODS: Force measurements were performed in cardiomyocytes isolated from a HCM patient carrying a homozygous troponin T mutation (cTnT-K280N) and healthy donors. To discriminate between mutation-mediated and phosphorylation-related effects on Ca(2+)-sensitivity, cardiomyocytes were treated with alkaline phosphatase (AP) or protein kinase A (PKA). Troponin exchange experiments characterized the relation between mutant levels and myofilament function. To define mutation-mediated effects on Ca(2+)-dynamics we used CRISPR/Cas9 to generate hiPSC-CMs harbouring heterozygous and homozygous TnT-K280N mutations. Ca(2+)-transient and cell shortening experiments compared these lines against isogenic controls. RESULTS: Myofilament Ca(2+)-sensitivity was higher in homozygous cTnT-K280N cardiomyocytes and was not corrected by AP- and PKA-treatment. In cTnT-K280N cells exchanged with cTnT-WT, a low level (14%) of cTnT-K280N mutation elevated Ca(2+)-sensitivity. Similarly, exchange of donor cells with 45 ± 2% cTnT-K280N increased Ca(2+)-sensitivity and was not corrected by PKA. cTnT-K280N hiPSC-CMs show elevated diastolic Ca(2+) and increases in cell shortening. Impaired cardiomyocyte relaxation was only evident in homozygous cTnT-K280N hiPSC-CMs. CONCLUSIONS: The cTnT-K280N mutation increases myofilament Ca(2+)-sensitivity, elevates diastolic Ca(2+), enhances contractility and impairs cellular relaxation. A low level (14%) of the cTnT-K280N sensitizes myofilaments to Ca(2+), a universal finding of human HCM. Elsevier, Inc 2022-09 /pmc/articles/PMC10160007/ /pubmed/37159677 http://dx.doi.org/10.1016/j.jmccpl.2022.100007 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Sequeira, Vasco
Wang, Lili
Wijnker, Paul J.M.
Kim, Kyungsoo
Pinto, Jose R.
dos Remedios, Cris
Redwood, Charles
Knollmann, Bjorn C.
van der Velden, Jolanda
Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title_full Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title_fullStr Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title_full_unstemmed Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title_short Low expression of the K280N TNNT2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
title_sort low expression of the k280n tnnt2 mutation is sufficient to increase basal myofilament activation in human hypertrophy cardiomyopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160007/
https://www.ncbi.nlm.nih.gov/pubmed/37159677
http://dx.doi.org/10.1016/j.jmccpl.2022.100007
work_keys_str_mv AT sequeiravasco lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT wanglili lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT wijnkerpauljm lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT kimkyungsoo lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT pintojoser lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT dosremedioscris lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT redwoodcharles lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT knollmannbjornc lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy
AT vanderveldenjolanda lowexpressionofthek280ntnnt2mutationissufficienttoincreasebasalmyofilamentactivationinhumanhypertrophycardiomyopathy